Investing.com - Mylan (NASDAQ:MYL) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Mylan announced earnings per share of $1.11 on revenue of $2.73B. Analysts polled by Investing.com anticipated EPS of $1 on revenue of $2.74B.
Mylan shares are down 15.92% from the beginning of the year, still down 26.87% from its 52 week high of $23.11 set on February 6. They are under-performing the Nasdaq which is up 22.58% from the start of the year.
Mylan follows other major Healthcare sector earnings this month
Mylan's report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.43B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar